CONNOR THOMPSON: Open Payments
NPI 1598499865 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,346 in 153 payments from 29 companies in 2025. Trend: 2023 $0 · 2024 $1,117 · 2025 $3,346
Food & beverage: $3,259Education: $87
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $496 |
| PFIZER INC. | 27 | $310 |
| Lilly USA, LLC | 11 | $266 |
| Eisai Inc. | 13 | $263 |
| Teva Pharmaceuticals USA, Inc. | 7 | $240 |
| Lundbeck LLC | 9 | $200 |
| Biogen, Inc. | 7 | $162 |
| TG Therapeutics, Inc. | 6 | $159 |
| Novartis Pharmaceuticals Corporation | 7 | $130 |
| Neurocrine BioSciences, Inc. | 5 | $127 |
Products named: NURTEC ODT, Leqembi, QULIPTA, VYEPTI, AMYVID, BRIUMVI, AUSTEDO XR, UBRELVY.
Industry payments across MD — which companies pay providers there.
